Thoratec Corp. (NASDAQ: THOR) was the king of the stock drops in Wednesday’s after-hours trading session. The reason for its drop of about one-quarter of its value was that its quarterly revenue of $118.1 million was roughly $10 million shy of estimates.
Also, the company’s annual revenue guidance of $455 million to $470 million was under the estimate of $523 million. A $30 million accelerated share buyback announcement did not even help.
We have seen multiple analyst downgrades as well. This stock has lost more than 25% of its value and was hitting 52-week lows after the lower guidance and revenue.
Thoratec was downgraded to Neutral from Buy at Goldman Sachs, with its price target cut to $28 from $38 in the call. Credit Suisse also downgraded Thoratec to Neutral from Outperform, slashing its price target to $27 from $40.
Oppenheimer cut its price target to $35 from $41 on reduced estimates. The firm said that the Thrombosis concerns drove its sales miss by saying:
Guidance assumes the issues persist though the second half, though initiatives are under way to improve both (most prominently a recent update to the FDA label with a balanced thrombosis discussion and highlighting improved HMII outcomes since original DT approval). While the stock will likely get hit on the reduced guidance, we have seen significant lumpiness in this market before and focus should shift to HMIII with the CE Mark trial under way.
Thoratec shares opened down at a new 52-week low, and unfortunately things went from awful to even worse. The stock opened at $24.11, versus a $32.57 close, and at 10:45 a.m. Eastern Time we saw the stock down 29.6% at $22.95. Trading volume was over 5.2 million shares, close to 10 times an average day’s trading volume.
ALSO READ: Jefferies Picks Top Franchise Stocks to Buy
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
